Eye Supplement Pioneer Develops Program to Manage AMD Risk Factor

ST. LOUIS, May 4 /PRNewswire/ -- ZeaVision, LLC introduced Eye-Q™, an intelligent AMD Risk Management program for EyeCare Professionals and patients to manage a key risk factor for Age-related Macular Degeneration (AMD).

AMD is a debilitating disease that affects the macula in the center of the eye, which is responsible for central vision. Affecting approximately 15 million people, AMD is irreversible and the leading cause of blindness in people over age 55.  

The Eye-Q™ program allows EyeCare Professionals to Measure, Manage, Monitor, and Maintain healthy macular pigment. Low macular pigment is a critical risk factor for AMD. Eye-Q™ includes QuantifEye®, a state-of-the-art measurement device that measures macular pigment level. When patients are diagnosed with low macular pigment, EyeCare Professionals often prescribe EyePromise® Restore, an all-natural supplement that contains a variety of nutrients including Zeaxanthin and Lutein - two carotenoids found in the macula. Macular pigment acts as a protective film or "internal sunglasses" to protect the eye from harmful blue light and oxidative stress. EyeCare Professionals and patients are encouraged to download an informative whitepaper on the Eye-Q™ program by visiting http://www.zeavision.com/eyeq

ZeaVision's Founder, Chairman, and CEO, Dennis Gierhart, PhD, explains Eye-Q™, "We patented Zeaxanthin nearly a decade ago and since then millions of servings of EyePromise have been consumed. Additionally, the QuantifEye® device has measured millions of eyes since its market introduction in 2006. Combining these components into a comprehensive AMD Risk Management program allows EyeCare Professionals and patients to be proactive in fighting AMD. Our company's mission is to develop supplements and other eyecare products to preserve healthy vision."

The best defense in fighting AMD are knowing the risk factors and measuring macular pigment levels early and often. In addition to low macular pigment, other key risk factors include family history, poor dietary habits, light skin and eyes, present or past smoking, female gender, and high body mass index. EyeCare Professionals and patients can download whitepapers on the Eye-Q program and ZeaVision offers a variety of resources at their website, http://www.zeavision.com

Photo of QuantifEye:

http://www.ereleases.com/pic/QuantifEye.jpg

Photo of EyePromise:  

http://www.ereleases.com/pic/EyePromise.jpg

Logos:

http://www.ereleases.com/pic/ZeaVision.gif

http://www.ereleases.com/pic/Eye-Q.gif

About ZeaVision

ZeaVision is Passionate About Prevention and develops products for EyeCare Professionals and consumers to maintain healthy vision. The company holds patents on Zeaxanthin, which is prominently featured in its EyePromise® Supplements. ZeaVision also markets QuantifEye®, a testing device that measures macular pigment, as well Eye-Q™, the company's comprehensive AMD Risk Management program. For more information, please visit http://www.zeavision.com or call 866-833-2800.

ZeaVision®, EyePromise®, QuantifEye®, and Eye-Q™ are the respective logos and registered trademarks of ZeaVision, LLC. All other trademarks herein are properties of their respective owners. All rights reserved.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE ZeaVision, LLC